These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical and pharmacoeconomic substantiation of the modification of eradication therapy regimens for Helicobacter pylori-associated diseases]. Grinevich VB, Samedov BKh, Uspenskiĭ IuP, Gubonina IV. Eksp Klin Gastroenterol; 2004; (2):16-21. PubMed ID: 15462313 [No Abstract] [Full Text] [Related]
3. Gastric cancer following Helicobacter pylori eradication in duodenal ulcer patients. Zullo A, Hassan C, Eramo A, Morini S. Dig Liver Dis; 2006 Jul; 38(7):528-9. PubMed ID: 16522383 [No Abstract] [Full Text] [Related]
4. [Pharmacoeconomic analysis (ABC, VEN and frequency analysis) of treatment of non-complicated duodenal ulcer associated with Helicobacter pylori in the specialized in-patient clinic]. Guseĭnzade MG. Eksp Klin Gastroenterol; 2005 Jul; (2):88-94. PubMed ID: 15932162 [No Abstract] [Full Text] [Related]
11. [Age aspects of clinical-morphological characteristics and treatment of duodenal ulcer]. Gromov MS, Islamova EA, Osadchuk MA, Lipatova TE. Voen Med Zh; 2008 Nov; 329(11):43-9. PubMed ID: 19186524 [No Abstract] [Full Text] [Related]
12. The interleukin-1 RN polymorphism and Helicobacter pylori infection in the development of duodenal ulcer. Hsu PI, Li CN, Tseng HH, Lai KH, Hsu PN, Lo GH, Lo CC, Yeh JJ, Ger LP, Hsiao M, Yamaoka Y, Hwang IR, Chen A. Helicobacter; 2004 Dec; 9(6):605-13. PubMed ID: 15610073 [Abstract] [Full Text] [Related]
13. [Impact of the anti-Helicobacter therapy on the life quality of patients with duodenal ulcers]. Guseĭnzade MG. Eksp Klin Gastroenterol; 2005 Dec; (5):22-7. PubMed ID: 16518910 [No Abstract] [Full Text] [Related]
14. Prevalence of Helicobactor pylori in patients with perforated duodenal ulcer. Kumar S, Mittal GS, Gupta S, Kaur I, Aggarwal S. Trop Gastroenterol; 2004 Dec; 25(3):121-4. PubMed ID: 15682658 [Abstract] [Full Text] [Related]
15. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Xia B, Xia HH, Ma CW, Wong KW, Fung FM, Hui CK, Chan CK, Chan AO, Lai KC, Yuen MF, Wong BC. Aliment Pharmacol Ther; 2005 Aug 01; 22(3):243-9. PubMed ID: 16091062 [Abstract] [Full Text] [Related]
16. Childhood duodenal ulcer associated with Helicobacter pylori and ABO blood groups. Nijevitch AA, Khamidullina SV, Khamidullina FM. Am J Gastroenterol; 1999 May 01; 94(5):1424-5. PubMed ID: 10235243 [No Abstract] [Full Text] [Related]
17. The Italian Consensus Conference on duodenal ulcer treatment. Ital J Gastroenterol; 1993 May 01; 25(2):99-104. PubMed ID: 8513171 [No Abstract] [Full Text] [Related]
18. [Helicobacter pylori in patients with bleeding ulcer]. Lipnitskiĭ EM, Alekberadze AV. Khirurgiia (Mosk); 2008 May 01; (4):11-5. PubMed ID: 18454101 [Abstract] [Full Text] [Related]
19. Helicobacter pylori eradication prevents recurrence after simple closure of perforated duodenal ulcer. Bose AC, Kate V, Ananthakrishnan N, Parija SC. J Gastroenterol Hepatol; 2007 Mar 01; 22(3):345-8. PubMed ID: 17295765 [Abstract] [Full Text] [Related]
20. [Helicobacter pylori: to treat or not to treat?]. Schraier M. Acta Gastroenterol Latinoam; 1993 Mar 01; 23(3):195-7. PubMed ID: 8296521 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]